BIG Research Programmes

TRANSBIG is a translational research network of 30 world-class institutions in 12 countries. Learn more

NeoBIG is a biomarkers and drug development research programme centred around neo-adjuvant studies. Learn more

Print

Large-scale cooperation is crucial to make significant  advances in breast cancer research, reduce the wasteful duplication of effort, and optimally serve those affected by the disease.

The Breast International Group (BIG), a non-profit organisation for academic breast cancer research groups, facilitates breast cancer research internationally by stimulating cooperation between its members and other academic networks, and collaborating with, but working independently from, the pharmaceutical industry.

News

04/11/2009 - MINDACT progress report now available

The MINDACT brochure, explaining what the MINDACT trial is, has been updated and is available to download.

10/08/2009 - Chinese women join BIG 2-04 SUPREMO trial

Breast cancer patients have for the first time been recruited from China to join SUPREMO, a global trial of breast radiotherapy.

14/05/2009 - MINDACT: Pilot phase successfully completed

The BIG 3-04 MINDACT trial reached its first milestone, the “pilot phase” consisting of the first 800 enrolled patients, in November 2008.

11/05/2009 - Jill Rose award conferred to Dr Piccart

Dr Martine Piccart has been selected to receive the Breast Cancer Research Foundation (BCRF)’s 2009 Jill Rose Award.

© 2010 Breast International Group (BIG)-aisbl